The US Food and Drug Administration (FDA) has approved the first-ever vaccine for respiratory syncytial virus (RSV). The single-shot vaccine intended for use in adults aged 60 or older represents the culmination of six decades of research to protect the world from RSV. With the green light from the FDA on Wednesday, GSK’s Arexvy vaccine […] Continue reading ->
CEOs from the world’s largest pharmaceutical companies issued a call to G7 leaders on Friday to oppose the inclusion of intellectual property rights waivers and pathogen benefit sharing in the World Health Organization’s (WHO) pandemic treaty.  In meetings with Japanese Prime Minister and chair of next month’s G7 summit Fumio Kishida this week, a delegation […] Continue reading ->
International NGOs and activists have called out the US for siding with China to exclude the public from seeing drafts of the pandemic accord as it is being negotiated by World Health Organization (WHO) member states. “The attempt to create a veil of secrecy now surrounding the substantive and technical text-based negotiations on the WHO […] Continue reading ->
Although the drafting of the proposed global pandemic accord will happen behind closed doors, civil society organisations want a say as they’re often on the ground dealing with health emergencies. This emerged during the second day of the meeting of the World Organization’s (WHO) intergovernmental negotiating board (INB), which is just starting to discuss the […] Continue reading ->
Concerns about equity and financing dominated day one of the negotiations on a global pandemic accord’s zero draft at the World Health Organization’s (WHO) Geneva head office on Monday. Opening the fourth meeting of the intergovernmental negotiating body (INB) that is steering the process, WHO Director-General Dr Tedros Adhanom Ghebreyusus noted that various people had […] Continue reading ->